Previous Close | 0.5468 |
Open | 0.5320 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 0.5300 - 0.5549 |
52 Week Range | 0.4350 - 6.3700 |
Volume | |
Avg. Volume | 1,866,795 |
Market Cap | 28.337M |
Beta (5Y Monthly) | 1.93 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
On August 30, 2024, Morgan Stanley executed a significant transaction involving Outset Medical Inc (NASDAQ:OM), a company known for its innovative medical technology. This move reflects a strategic adjustment in Morgan Stanley's investment portfolio, despite the trade having a minimal immediate impact on its overall composition. Morgan Stanley, established in 1935, has evolved into a global financial services powerhouse with a presence in 42 countries.
On August 30, 2024, JPMorgan Chase & Co executed a significant transaction involving Outset Medical Inc (NASDAQ:OM), a player in the medical technology sector. This move has adjusted the firm's portfolio, reflecting a strategic shift in its investment stance towards Outset Medical Inc. JPMorgan Chase & Co, with a storied history dating back to 1799, stands today as a global financial behemoth with operations in over 60 countries.